Valeo Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $944K | Buy |
1,797
+609
| +51% | +$320K | 0.02% | 313 |
|
|
2025
Q1 | $753K | Sell |
1,188
-63
| -5% | -$39.9K | 0.02% | 318 |
|
|
2024
Q4 | $891K | Sell |
1,251
-296
| -19% | -$211K | 0.02% | 286 |
|
|
2024
Q3 | $1.63M | Buy |
1,547
+442
| +40% | +$465K | 0.05% | 182 |
|
|
2024
Q2 | $1.16M | Buy |
1,105
+210
| +23% | +$221K | 0.04% | 214 |
|
|
2024
Q1 | $811K | Buy |
895
+255
| +40% | +$231K | 0.03% | 269 |
|
|
2023
Q4 | $562K | Buy |
640
+21
| +3% | +$18.4K | 0.02% | 327 |
|
|
2023
Q3 | $509K | Buy |
619
+103
| +20% | +$84.8K | 0.02% | 328 |
|
|
2023
Q2 | $371K | Sell |
516
-98
| -16% | -$70.4K | 0.02% | 380 |
|
|
2023
Q1 | $505K | Buy |
614
+158
| +35% | +$130K | 0.02% | 338 |
|
|
2022
Q4 | $329K | Buy |
+456
| New | +$329K | 0.02% | 367 |
|
|
2022
Q1 | – | Sell |
-389
| Closed | -$246K | – | 612 |
|
|
2021
Q4 | $246K | Buy |
389
+6
| +2% | +$3.79K | 0.01% | 448 |
|
|
2021
Q3 | $232K | Buy |
383
+19
| +5% | +$11.5K | 0.01% | 438 |
|
|
2021
Q2 | $203K | Buy |
364
+4
| +1% | +$2.23K | 0.01% | 416 |
|
|
2021
Q1 | $170K | Sell |
360
-160
| -31% | -$75.6K | 0.01% | 470 |
|
|
2020
Q4 | $251K | Buy |
520
+1
| +0.2% | +$483 | 0.01% | 365 |
|
|
2020
Q3 | $291K | Buy |
519
+72
| +16% | +$40.4K | 0.03% | 253 |
|
|
2020
Q2 | $279K | Buy |
447
+22
| +5% | +$13.7K | 0.03% | 261 |
|
|
2020
Q1 | $218K | Buy |
425
+15
| +4% | +$7.69K | 0.02% | 281 |
|
|
2019
Q4 | $154K | Buy |
410
+350
| +583% | +$131K | 0.01% | 368 |
|
|
2019
Q3 | $17K | Sell |
60
-350
| -85% | -$99.2K | ﹤0.01% | 884 |
|
|
2019
Q2 | $128K | Buy |
410
+350
| +583% | +$109K | 0.01% | 376 |
|
|
2019
Q1 | $25K | Sell |
60
-50
| -45% | -$20.8K | ﹤0.01% | 710 |
|
|
2018
Q4 | $41K | Sell |
110
-343
| -76% | -$128K | 0.01% | 544 |
|
|
2018
Q3 | $154K | Sell |
453
-100
| -18% | -$34K | 0.02% | 319 |
|
|
2018
Q2 | $203K | Buy |
553
+500
| +943% | +$184K | 0.03% | 277 |
|
|
2018
Q1 | $18K | Hold |
53
| – | – | ﹤0.01% | 742 |
|
|
2017
Q4 | $20K | Buy |
53
+18
| +51% | +$6.79K | ﹤0.01% | 665 |
|
|
2017
Q3 | $16K | Buy |
+35
| New | +$16K | ﹤0.01% | 597 |
|